2024. Prevalence and serological evidence of Mycoplasma gallisepticum among commercial layers. Frontiers in Microbiology and Biotechnology. 3, 01 (Dec. 2024), 1–8. DOI:https://doi.org/10.54219/fmb.03.2024.213.